Login
Home
Charts
Search
Watchlist
Products

Royal Orchid Hotels Ltd

ROHLTD·NSE
306.00-0.81%Tue, 22 Sept '26 15:54

Royal Orchid Hotels Ltd

ROHLTD
NSE
306.00
-0.81%
|Tue, 22 Sept '26 15:54
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
839Cr
Close
Close Price
305.95
Industry
Industry
Hotels
PE
Price To Earnings
30.32
PS
Price To Sales
2.03
Revenue
Revenue
413Cr
Rev Gr TTM
Revenue Growth TTM
26.86%
PAT Gr TTM
PAT Growth TTM
-47.98%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
678276737089877979113113107
Growth YoY
Revenue Growth YoY%
14.713.05.06.05.79.013.87.912.526.630.536.1
Expenses
ExpensesCr
515758565964675966838882
Operating Profit
Operating ProfitCr
152518171125202013302625
OPM
OPM%
23.230.223.322.816.328.123.024.916.726.522.623.7
Other Income
Other IncomeCr
356586648587
Interest Expense
Interest ExpenseCr
554444449131313
Depreciation
DepreciationCr
555555558111112
PBT
PBTCr
102014121022161541098
Tax
TaxCr
25-1335541332
PAT
PATCr
71515971611114866
Growth YoY
PAT Growth YoY%
-19.53.726.2-16.4-8.712.6-24.626.4-47.4-52.9-43.3-45.9
NPM
NPM%
11.217.719.911.79.718.313.213.74.56.85.75.4
EPS
EPS
2.55.66.13.22.76.54.84.01.63.32.92.3
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
678276737089877979113113107
Growth YoY
Revenue Growth YoY%
14.713.05.06.05.79.013.87.912.526.630.536.1
Expenses
ExpensesCr
515758565964675966838882
Operating Profit
Operating ProfitCr
152518171125202013302625
OPM
OPM%
23.230.223.322.816.328.123.024.916.726.522.623.7
Other Income
Other IncomeCr
356586648587
Interest Expense
Interest ExpenseCr
554444449131313
Depreciation
DepreciationCr
555555558111112
PBT
PBTCr
102014121022161541098
Tax
TaxCr
25-1335541332
PAT
PATCr
71515971611114866
Growth YoY
PAT Growth YoY%
-19.53.726.2-16.4-8.712.6-24.626.4-47.4-52.9-43.3-45.9
NPM
NPM%
11.217.719.911.79.718.313.213.74.56.85.75.4
EPS
EPS
2.55.66.13.22.76.54.84.01.63.32.92.3

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
15917518920420581139264294319384413
Growth
Revenue Growth%
7.310.38.37.60.6-60.671.390.311.48.820.326.9
Expenses
ExpensesCr
13815616017017492116182218246296318
Operating Profit
Operating ProfitCr
2019293431-11238276738894
OPM
OPM%
12.810.815.516.514.9-13.716.631.125.922.923.022.8
Other Income
Other IncomeCr
6131015151421619242428
Interest Expense
Interest ExpenseCr
151515131616161618173948
Depreciation
DepreciationCr
141616141919191820213642
PBT
PBTCr
-3092111-46306457593832
Tax
TaxCr
15786-63171016108
PAT
PATCr
-4-52135-40274747432924
Growth
PAT Growth%
46.3-25.1152.9443.5-61.3-888.0166.975.20.9-8.9-33.8-48.0
NPM
NPM%
-2.3-2.61.36.42.5-49.519.317.816.113.57.45.7
EPS
EPS
-0.5-1.70.94.81.8-11.810.717.117.717.211.710.1
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
15917518920420581139264294319384413
Growth
Revenue Growth%
7.310.38.37.60.6-60.671.390.311.48.820.326.9
Expenses
ExpensesCr
13815616017017492116182218246296318
Operating Profit
Operating ProfitCr
2019293431-11238276738894
OPM
OPM%
12.810.815.516.514.9-13.716.631.125.922.923.022.8
Other Income
Other IncomeCr
6131015151421619242428
Interest Expense
Interest ExpenseCr
151515131616161618173948
Depreciation
DepreciationCr
141616141919191820213642
PBT
PBTCr
-3092111-46306457593832
Tax
TaxCr
15786-63171016108
PAT
PATCr
-4-52135-40274747432924
Growth
PAT Growth%
46.3-25.1152.9443.5-61.3-888.0166.975.20.9-8.9-33.8-48.0
NPM
NPM%
-2.3-2.61.36.42.5-49.519.317.816.113.57.45.7
EPS
EPS
-0.5-1.70.94.81.8-11.810.717.117.717.211.710.1

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
2727272727272727272727
Reserves
ReservesCr
13313914215014611398146163203231
Current Liabilities
Current LiabilitiesCr
818284879510177808999146
Non Current Liabilities
Non Current LiabilitiesCr
6511110594139145138147173192620
Total Liabilities
Total LiabilitiesCr
3424084024044494193634244705381,042
Current Assets
Current AssetsCr
375562737512882116101121155
Non Current Assets
Non Current AssetsCr
306353340331373291281308369417863
Total Assets
Total AssetsCr
3424084024044494193634244705381,042
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
2727272727272727272727
Reserves
ReservesCr
13313914215014611398146163203231
Current Liabilities
Current LiabilitiesCr
818284879510177808999146
Non Current Liabilities
Non Current LiabilitiesCr
6511110594139145138147173192620
Total Liabilities
Total LiabilitiesCr
3424084024044494193634244705381,042
Current Assets
Current AssetsCr
375562737512882116101121155
Non Current Assets
Non Current AssetsCr
306353340331373291281308369417863
Total Assets
Total AssetsCr
3424084024044494193634244705381,042

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
232725412952256592582
Investing Cash Flow
Investing Cash FlowCr
-7-9-1-5-16-11-3-9-37-22-39
Financing Cash Flow
Financing Cash FlowCr
-16-11-18-23-28-1-13-25-390-56
Net Cash Flow
Net Cash FlowCr
07613-15-6621-163-13
Free Cash Flow
Free Cash FlowCr
231921362442045481
CFO To PAT
CFO To PAT%
-639.6-585.01,034.1310.9575.3-13.281.5118.3125.457.3288.0
CFO To EBITDA
CFO To EBITDA%
114.6140.785.0121.395.4-47.695.167.878.133.893.1
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
232725412952256592582
Investing Cash Flow
Investing Cash FlowCr
-7-9-1-5-16-11-3-9-37-22-39
Financing Cash Flow
Financing Cash FlowCr
-16-11-18-23-28-1-13-25-390-56
Net Cash Flow
Net Cash FlowCr
07613-15-6621-163-13
Free Cash Flow
Free Cash FlowCr
231921362442045481
CFO To PAT
CFO To PAT%
-639.6-585.01,034.1310.9575.3-13.281.5118.3125.457.3288.0
CFO To EBITDA
CFO To EBITDA%
114.6140.785.0121.395.4-47.695.167.878.133.893.1

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1922444393241121723357429931,075743839
Price To Earnings
Price To Earnings
130.727.122.911.415.820.522.823.130.3
Price To Sales
Price To Sales
1.21.42.31.60.62.12.42.83.43.41.92.0
Price To Book
Price To Book
1.21.52.61.80.71.22.74.35.24.72.93.3
EV To EBITDA
EV To EBITDA
12.217.217.411.17.0-26.319.010.115.017.09.115.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
67.567.470.569.668.258.765.772.371.371.2
OPM
OPM%
12.810.815.516.514.9-13.716.631.125.922.923.022.8
NPM
NPM%
-2.3-2.61.36.42.5-49.519.317.816.113.57.45.7
ROCE
ROCE%
5.35.88.912.88.3-9.816.824.119.316.821.721.7
ROE
ROE%
-2.3-2.71.47.42.9-28.521.427.124.818.711.111.1
ROA
ROA%
-1.1-1.10.63.31.1-9.67.411.110.18.02.72.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1922444393241121723357429931,075743839
Price To Earnings
Price To Earnings
130.727.122.911.415.820.522.823.130.3
Price To Sales
Price To Sales
1.21.42.31.60.62.12.42.83.43.41.92.0
Price To Book
Price To Book
1.21.52.61.80.71.22.74.35.24.72.93.3
EV To EBITDA
EV To EBITDA
12.217.217.411.17.0-26.319.010.115.017.09.115.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
67.567.470.569.668.258.765.772.371.371.2
OPM
OPM%
12.810.815.516.514.9-13.716.631.125.922.923.022.8
NPM
NPM%
-2.3-2.61.36.42.5-49.519.317.816.113.57.45.7
ROCE
ROCE%
5.35.88.912.88.3-9.816.824.119.316.821.721.7
ROE
ROE%
-2.3-2.71.47.42.9-28.521.427.124.818.711.111.1
ROA
ROA%
-1.1-1.10.63.31.1-9.67.411.110.18.02.72.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Royal Orchid Hotels began not as a property developer but as a hospitality company built on good food, and that instinct - that a hotel is an experience, not just a building - still shapes everything it does. Founded in 1986 by IIM Ahmedabad alumnus Chander Baljee and listed in 2006, the company has transformed over the last few years from a traditional hotel owner into an asset-light operator that manages and franchises hotels far more than it owns them. The recurring approach is simple: create a brand for every traveller and every owner, then grow by signing management contracts rather than pouring capital into bricks and mortar. # Business segments A single hospitality engine that designs, sells and runs branded hotels - but earns its fees through five distinct contract types, each with a different risk-and-reward profile for the company and the property owner. ## 1. Managed and franchised hotels: the asset-light growth engine **Roughly four out of every five rooms Royal Orchid operates are owned by someone else - the company collects a fee for running the hotel or lending its brand, needing almost no capital of its own.** - **Fee on revenue, not just profit** - under a management contract, the company earns a percentage of the hotel’s top line plus a share of operating profit, so it gets paid even before the owner sees a return. - **Franchise fees from “educated owners”** - some property owners want to run the hotel themselves but need a known brand and distribution; Royal Orchid charges them a percentage of revenues as a franchise fee and provides exactly that. - **Capital-light by design** - the management business needs only limited maintenance capex, breaks even on operating profit within a year, and delivers a return on capital of around 75-80%, with roughly 40-45% of that flowing to the bottom line. - **The pipeline is the future** - as of May 2026, the company had 52 signed hotels with 3,600 rooms in the pipeline, and property owners now approach Royal Orchid rather than the other way around. ## 2. Revenue-share and flexi-lease hotels: sharing the upside, limiting the downside **In these hybrid arrangements, the owner gets a rent tied to the hotel’s top line while Royal Orchid runs the profit-and-loss statement - the owner bears no downside risk, and the company keeps what is left after paying the revenue-linked rent.** - **A percentage of sales as rent** - instead of a fixed lease, the company pays the owner an agreed share of the hotel’s top line, which means rent rises and falls with the business. - **The company controls operations** - Royal Orchid manages the full P&L, so it can drive efficiency and service quality directly, unlike in a pure franchise. - **A targeted slice of the portfolio** - the company aims for 10-15% of future hotels to sit under this revenue-share model, balancing growth with the higher operational involvement it demands. ## 3. Owned and leased hotels: the foundation that built the brand **Three owned hotels and five leased ones provide the physical proof of concept - these are the properties where the brands were born and where the company still invests its own capital to renovate and expand.** - **The original playbook** - the first Royal Orchid Hotel opened in Bangalore in 2001, and the company grew from two to ten owned and leased hotels in six years, establishing the operational know-how that now powers the management business. - **A stable base of 1,442 keys** - across owned and leased properties, these rooms give the company direct control over flagship locations and a laboratory for testing brand standards before rolling them out to managed hotels. ## 4. The House of Brands: a hotel for every traveller and every owner **Seven brands span budget to upscale, each with a distinct personality - from a Gen Z-focused budget chain to an upscale lifestyle brand at Mumbai Airport - so the company can sign a property in almost any location and match it to the right guest.** - **Royal Orchid Hotels & Resorts** - the flagship upscale brand, representing about 6-8% of keys, aimed at the five-star segment. - **Iconiqa Hotels & Resorts** - an upscale lifestyle brand, deliberately positioned below five-star luxury, with different room design and service; the first property at Mumbai Airport T2 was rated number one on TripAdvisor within four months of opening. - **Z by Regenta** - the budget brand built for Gen Z and millennial travellers, described as “the everywhere budget hotel brand to explore every neighbourhood”. - **Crestoria Hotels & Resorts** - boutique properties offering local experiences, rounding out a portfolio that also includes service apartments and resort destinations. ## 5. Food, banqueting and the wedding economy: the experience layer **With over 180 restaurants and a deliberate focus on India’s massive wedding market, the company turns its hotels into dining and celebration venues - not just places to sleep.** - **Origins in good food** - the company’s founding strength in hotel restaurants now supports 180-plus specialty and all-day dining outlets across its properties, generating revenue from guests and locals alike. - **Marriage tourism at scale** - India’s wedding market was estimated at $50 billion, and Royal Orchid has identified roughly 20 hotels with large banqueting spaces, marketing them directly to wedding planners with dedicated brochures and a website tab. - **Dynamic pricing, like airlines** - room rates are adjusted daily, sometimes more than once a day, to capture demand from business travellers, leisure guests, and the growing pilgrimage segment. # Group structure and partners **A family-led public company with a 63.6% promoter holding, now allied with Hilton to open 125 hotels under a global brand by 2035.** - **Promoter leadership** - Chairman Chander Baljee holds 39.22% of the equity; his sons Arjun Baljee (President) and Keshav Baljee (Whole-time Director) run operations and strategy day-to-day. - **The Hilton franchise deal** - in April 2026, the company signed a strategic agreement through its subsidiary Regenta Hotels Private Limited to open 125 Hampton by Hilton hotels across six western and southern states by 2035, adding a global midscale brand to its own portfolio. - **Exit from subsidiary** - the company sold its 96.37% stake in its dormant subsidiary Multi Hotels Limited in early 2026, closing the chapter on an international venture that never commenced operations.

Documents — Royal Orchid Hotels Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/i61ep5k2wjd0kvyd2l4zjr8q.pdf
  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/9yxkhpgz0nq3xkgu4b1uzwgo.pdf
  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/7u43xrkw6d95fdytud2nsy01.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/rez4amj4872y6j8zhxzwcw2b.pdf
  • Q4 FY2025 Earnings Call Transcript (Mar 2025, PDF): https://www.stockscans.in/document/c34nq3vgrrxbxik7qgete0rt.pdf
  • Q3 FY2025 Earnings Call Transcript (Dec 2024, PDF): https://www.stockscans.in/document/3r2g6xqdmy4t6qng5a84100f.pdf
  • Q2 FY2025 Earnings Call Transcript (Sep 2024, PDF): https://www.stockscans.in/document/02x3e7pgdqk6gmib7ax82kvo.pdf
  • Q1 FY2025 Earnings Call Transcript (Jun 2024, PDF): https://www.stockscans.in/document/vhqvp93nt7h57caeymusydbf.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/lgs5yoih8qfowli3t113jqhh.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/fcf0b5jps9pxq54duam8nblf.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/6eog1urmpq5hp6pyhnvxz1t8.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/yr6pzjn0xw94zzbczpsm4ol5.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/a5yy6dsraql57cbvhrfxfg0s.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/60tjhtro6o2wsf4elzx8juvy.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/dxlonk5t6oc988hxhues8bkz.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/tdo9wqop9g60zqycrxfw1sxd.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/sirte8bqhazduwo10fm3pfa0.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/44g8aigmbugodf428ldnfxo3.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/l1gu73ke9alrpmnortp98pws.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/b7zl530rmztdm2od5xbyy945.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/89h6q3znjkop3e8sipdy9mwv.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/cjl2uzcg1xcaft230rgxghiu.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/wqd4bc7jlrfitm8jcd3i484t.pdf
  • Q1 FY2025 Investor Presentation (Jun 2024, PDF): https://www.stockscans.in/document/h3dz1e4spnz7phjwzkf5z4mq.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/1fl3ox4zk08p7e4rj5fgqv1n.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/upsdeu9y1g8aoycoyvtxj94j.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/fhtbm1occo190ykpa92clfft.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/a8t40p6mqckp2mda9kaqe1y8.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/zae9ve1l2kw61uz33vitcqks.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/4hwr036w9v9x9qjbciz3mdd1.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/0vc5y1ecie85yidlzmaemb6g.pdf

Concall Transcript Summaries — Royal Orchid Hotels Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3AROHLTD/transcript-notes/202606/i61ep5k2wjd0kvyd2l4zjr8q.pdf
  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3AROHLTD/transcript-notes/202603/9yxkhpgz0nq3xkgu4b1uzwgo.pdf
  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/NSE%3AROHLTD/transcript-notes/202512/7u43xrkw6d95fdytud2nsy01.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3AROHLTD/transcript-notes/202509/rez4amj4872y6j8zhxzwcw2b.pdf
  • Q4 FY2025 Concall Transcript Summary (Mar 2025): https://www.stockscans.in/company/NSE%3AROHLTD/transcript-notes/202503/c34nq3vgrrxbxik7qgete0rt.pdf
  • Q3 FY2025 Concall Transcript Summary (Dec 2024): https://www.stockscans.in/company/NSE%3AROHLTD/transcript-notes/202412/3r2g6xqdmy4t6qng5a84100f.pdf
  • Q2 FY2025 Concall Transcript Summary (Sep 2024): https://www.stockscans.in/company/NSE%3AROHLTD/transcript-notes/202409/02x3e7pgdqk6gmib7ax82kvo.pdf
  • Q1 FY2025 Concall Transcript Summary (Jun 2024): https://www.stockscans.in/company/NSE%3AROHLTD/transcript-notes/202406/vhqvp93nt7h57caeymusydbf.pdf